Accel Wealth Management’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-95
Closed -$27K 940
2021
Q3
$27K Hold
95
0.02% 442
2021
Q2
$19K Hold
95
0.01% 563
2021
Q1
$18K Sell
95
-55
-37% -$11.3K 0.01% 537
2020
Q4
$29K Buy
+150
New +$27.3K 0.03% 412

Other funds holding RGEN

Accel Wealth Management's RGEN Position: Q4 2021 in Review

Accel Wealth Management sold out of Repligen (RGEN) in Q4 2021, closing a stake of 95 shares — an estimated $27K sold.

Accel Wealth Management first reported a position in RGEN in Q4 2020 and held it in 4 quarters. The position peaked at $29K in Q4 2020. 507 funds tracked by Wall St. Rank hold RGEN as of Q4 2021.

  • Accel Wealth Management reported no remaining Repligen position as of Q4 2021 after selling out during the quarter.
  • Accel Wealth Management sold 95 Repligen shares in Q4 2021, an estimated $27K.
  • Accel Wealth Management first reported a position in Repligen in Q4 2020 and held it in 4 quarters.
  • Accel Wealth Management's Repligen position peaked at $29K in Q4 2020.
  • 507 funds tracked by Wall St. Rank held Repligen as of Q4 2021.

Based on Accel Wealth Management's 13F filing for Q4 2021, filed 18 Jan 2022.